High doses of some statins may provide cancer protection

05/16/2008 | Reuters

A new study found people who took high doses of statins that are lipophilic, or soluble in fats -- such as Lipitor, Zocor and Mevacor -- had a 25% lower risk of cancer than those who did not use the cholesterol-lowering medications. People taking a lower dose reduced their cancer risk by 11%.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY